Italy
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1.45
|
Dec. 31, 2023 | USD 9.94 | -2.22% |
|
Italy |
|
2 |
1.07
|
Dec. 31, 2023 | USD 60.99 | 0.24% |
|
Italy |
|
3 |
0.77
|
Dec. 31, 2023 | USD 106.54 | -0.80% |
|
Italy |
|
4 |
0.51
|
Dec. 31, 2023 | USD 53.53 | 1.54% |
|
Italy |
|
5 |
0.35
|
Dec. 31, 2023 | USD 22.41 | 2.19% |
|
Italy |
|
6 |
0.16
|
Dec. 31, 2023 | USD 18.53 | 2.23% |
|
Italy |
|
7 |
0.04
|
Dec. 31, 2023 | USD 1.99 | -0.60% |
|
Italy |
|
8 |
-1.62
|
Dec. 31, 2023 | USD 10.28 | -2.46% |
|
Italy |
The Healthcare company in Italy with the highest Debt to Equity Ratio is GPI S.p.A. (Milan Stock Exchange: GPI.MI) at 1.45.
The Healthcare company in Italy with the lowest Debt to Equity Ratio is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at -1.62.
The top 10 Healthcare companies in Italy by Debt to Equity Ratio are GPI S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A., DiaSorin S.p.A., Pharmanutra S.p.A., Stevanato Group S.p.A., Philogen S.p.A., Arterra Bioscience and Newron Pharmaceuticals S.p.A..
The bottom 10 Healthcare companies in Italy by Debt to Equity Ratio are Newron Pharmaceuticals S.p.A., Arterra Bioscience, Philogen S.p.A., Stevanato Group S.p.A., Pharmanutra S.p.A., DiaSorin S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A. and GPI S.p.A..